MIRM MIRUM PHARMACEUTICALS INC
2026Q1 · CUSIP 604749101 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
309
Δ holders QoQ
+25
Breadth percentile
Top 12%
Whale holders
152
Δ whales
+7
Inst. holding value
$6.3B
New positions
67
Closed positions
42
Price momentum (1Q)
-7.1%
Put / Call
3/4
Breadth history (34 quarters)
Past Lit Events & Aftermath 11 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 12% | — | — |
| 2025Q3 | Top 4% | +46.1% | +34.3% |
| 2024Q4 | Top 19% | -14.8% | +23.6% |
| 2024Q3 | Top 20% | +26.6% | +6.3% |
| 2023Q4 | Top 19% | -17.8% | +42.9% |
| 2023Q3 | Top 15% | -4.0% | -16.5% |
| 2023Q2 | Top 6% | +22.8% | +17.3% |
| 2023Q1 | Top 12% | -5.9% | +16.0% |
Options Sentiment
Put holders
3
QoQ: +1
Call holders
4
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-13.60
EPS YoY
—
Revenue (TTM)
$0.6B
Revenue YoY
+50.2%
Net margin
-140.2%
ROE
-329.4%
Debt ratio
72.8%
FCF (TTM)
-$173M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.